TYPE 2 DIABETES MELLITUS AND COGNITIVE IMPAIRMENT: A REVIEW OF CURRENT EVIDENCE

Asadova Nozima Sherzodovna, Rakhimova Gulnora Nishanovna

Klinik fanlar yilnomasi · 2026-yil

Annotatsiya

Type 2 diabetes mellitus (T2DM) is a significant risk factor for the development of cognitive impairment and dementia. Metabolic, vascular, and inflammatory mechanisms arising from chronic hyperglycemia and insulin resistance lead to structural and functional changes in the central nervous system. This study presents a comprehensive assessment of cognitive status in patients with T2DM, analyzing the impact of clinical and metabolic parameters as well as glucose-lowering therapy. It was found that disease duration, HbA1c levels, and the presence of vascular complications are associated with the severity of cognitive decline. The obtained data confirm the need for early screening of cognitive impairment in patients with T2DM and a rational choice of therapy with potential neuroprotective effects.

Maqola ma’lumotlari
MualliflarAsadova Nozima Sherzodovna, Rakhimova Gulnora Nishanovna
JurnalKlinik fanlar yilnomasi
Nashr sanasi2026-05-02
Jild3
Son1/1
TilRus

Kalit so‘zlar

type 2 diabetes mellitus, cognitive impairment, dementia, hyperglycemia, neuroinflammation, hypoglycemic therapy, сахарный диабет 2 типа, когнитивные нарушения, деменция, гипергликемия, нейровоспаление, гипогликемизирующая терапия, 2-tur qandli diabet, kognitiv buzilishlar, demensiya, giperglikemiya, neyroyallig‘lanish, gipoglikemik terapiya

Ilmiy soha

Klinik fanlar yilnomasi jurnalidan boshqa maqolalar

Klinik fanlar yilnomasi — barcha maqolalar